For the epidemic situation, if there is a drug with obvious curative effect, it is of great significance both for the social situation and the disease.
On February 4, according to Changjiang Daily, Li Lanjuan, academician of the Chinese Academy of engineering and member of the high level expert group of the National Health Commission, announced the latest research results on the treatment of pneumonia caused by the new coronavirus in Wuhan.
Academician Li Lanjuan said that according to the preliminary test, in vitro cell experiments showed that: (1) compared with the untreated control group, abidol can effectively inhibit the coronavirus to 60 times, and significantly inhibit the pathological effect of the virus on cells. (2) Compared with the control group, the inhibition efficiency of darunavir was 280 times.
Academician Li Lanjuan said that the anti AIDS drug klitschke had poor effect on the treatment of pneumonia caused by new coronavirus infection, and had toxic side effects. She suggested that the above two drugs should be included in the National Health Commission's "diagnosis and treatment plan for pneumonia with new coronavirus infection (trial version 6)".
Chen Zuobin, member of Academician Li Lanjuan's team, leader of Zhejiang aid Hubei severe treatment group and vice president of Zhejiang University First Hospital, reminded that "these two drugs are prescription drugs, and patients must take them under the guidance of doctors." He also said that now the two drugs have been used in pneumonia patients infected with new coronavirus in Zhejiang Province, and the next plan is to replace other drugs with the two drugs with poor effect.
Hot Model No.: